Dandekar Atul sold MAZE
September 3, 2026 · Form 4 insider transaction
Dandekar Atul sold 36 shares of Maze Therapeutics, Inc. at $25.81 per share, a transaction worth $929.16. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
36
Price
$25.81
Total value
$929.16
InsiderDandekar Atul
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 3, 2026
Filing dateSeptember 4, 2026
Shares owned after32,316
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units.